Patients with incompletely registered two-stage procedures did not differ from those with complete information at the time of their index surgery in terms of age (≥80y: 6% vs 6%; ≤60y: 30% vs 29%), sex (female: 43% vs 46%), BMI (<25kg/m 2 : 16% vs 13%;≥30kg/m 2 :
55% vs 55%), American Society of Anaesthesiologists (ASA) Physical Status grade (>P2: 16% vs 15%), or type of surgery (uncemented total hip replacement: 39% vs 42%; resurfacing: 9% vs 7%).
For patients with incompletely registered two-stage revision procedures, the date of the first revision operation and the period they had been at risk of revision for PJI were estimated. We initially derived the relative weight of time elapsed between the index and the first operation by year and type of index surgery using patients with complete information: 100 x (length of timeindex surgery-1st operation/length of time index surgery-2nd operation). We then applied these weights to the length of time between the index and the second procedure for those with incomplete information to obtain an estimated "index surgery-1 st operation" duration.
Data on comorbidity were derived from the HES records. HES hospital admissions were linked to the NJR using a common anonymised patient identifier provided to NJR end-user by Northgate. The presence of each of the following comorbidities was identified using the ICD-10 codes associated with each hospital admission which occurred in the five years preceding the date of the primary replacement recorded in the NJR. The PEDW records were similarly linked but the dates of hospital admission were either missing or incomplete in the data extract available to us for numerous records preventing the accurate derivation of the five-year comorbidity presence. The comorbidity profile of patients with records in PEDW and/or operated in Wales could not be established with accuracy. The analysis of the effect of specific comorbidity on revision for PJI was therefore restricted to patients with a hip replacement performed in England with linked HES record(s), with no record in the PEDW and no evidence of residency outside England. In other words, patients with their hip replacement performed in England but with PEDW record(s), patients with their hip replacement performed in Wales with or without PEDW/HES record(s) and patients with evidence of residency outside England were excluded. Moreover to reduce a risk of misclassification bias, patients operated in England with unlinked HES or PEDW record(s) could not be included in these analyses, i.e. not accounted as healthy patients: It was impossible to disentangle those who were genuinely healthy (i.e. absence of HES and PEDW record=true absence of any hospitalisation) from those who had been admitted to the hospital for any reason but for whom linkage between their NJR and HES/PEDW records could not be established(either due to missing data in the HES/PEDW file or of absence of match with the linkage method used by Northgate). No major evidence of difference was identified between included (n=495,456, Figure1) and excluded (n=623,253-495,456=127,797, figure1) patients: median age 68y vs 69y, Male=42% vs 40%, median BMI 27 vs 28. However, those included had worse ASA grade (healthy patient(ASA=1): 17% vs 25%; mild systemic disease (ASA=2): 68% vs 4%; severe systemic disease (ASA=3): 15% vs 10%). This is expected as patients with HES records have at least one comorbidity and as explained above, some of the patients without a HES record are "healthy" patients with no comorbidity requiring hospital inpatient admission or hospital outpatient visit." The comorbidities considered were derived from the Charlson comorbidity index using the following ICD-10 codes: 
